These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

321 related articles for article (PubMed ID: 27911308)

  • 1. The Effects of Gene Mutations on Default Mode Network in Familial Alzheimer's Disease.
    Li X; Westman E; Thordardottir S; Ståhlbom AK; Almkvist O; Blennow K; Wahlund LO; Graff C
    J Alzheimers Dis; 2017; 56(1):327-334. PubMed ID: 27911308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Preclinical cerebrospinal fluid and volumetric magnetic resonance imaging biomarkers in Swedish familial Alzheimer's disease.
    Thordardottir S; Ståhlbom AK; Ferreira D; Almkvist O; Westman E; Zetterberg H; Eriksdotter M; Blennow K; Graff C
    J Alzheimers Dis; 2015; 43(4):1393-402. PubMed ID: 25182737
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relevance of cerebrospinal fluid α-synuclein levels to sporadic and familial Alzheimer's disease.
    Twohig D; Rodriguez-Vieitez E; Sando SB; Berge G; Lauridsen C; Møller I; Grøntvedt GR; Bråthen G; Patra K; Bu G; Benzinger TLS; Karch CM; Fagan A; Morris JC; Bateman RJ; Nordberg A; White LR; Nielsen HM;
    Acta Neuropathol Commun; 2018 Nov; 6(1):130. PubMed ID: 30477568
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Functional Connectivity of Default Mode Network Subsystems in the Presymptomatic Stage of Autosomal Dominant Alzheimer's Disease.
    Zhao T; Quan M; Jia J
    J Alzheimers Dis; 2020; 73(4):1435-1444. PubMed ID: 31929167
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Proteomic changes in cerebrospinal fluid of presymptomatic and affected persons carrying familial Alzheimer disease mutations.
    Ringman JM; Schulman H; Becker C; Jones T; Bai Y; Immermann F; Cole G; Sokolow S; Gylys K; Geschwind DH; Cummings JL; Wan HI
    Arch Neurol; 2012 Jan; 69(1):96-104. PubMed ID: 22232349
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Distinctive Resting State Network Disruptions Among Alzheimer's Disease, Subcortical Vascular Dementia, and Mixed Dementia Patients.
    Kim HJ; Cha J; Lee JM; Shin JS; Jung NY; Kim YJ; Choe YS; Lee KH; Kim ST; Kim JS; Lee JH; Na DL; Seo SW
    J Alzheimers Dis; 2016; 50(3):709-18. PubMed ID: 26757039
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Network Disruption and Cerebrospinal Fluid Amyloid-Beta and Phospho-Tau Levels in Mild Cognitive Impairment.
    Canuet L; Pusil S; López ME; Bajo R; Pineda-Pardo JÁ; Cuesta P; Gálvez G; Gaztelu JM; Lourido D; García-Ribas G; Maestú F
    J Neurosci; 2015 Jul; 35(28):10325-30. PubMed ID: 26180207
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Habitual exercise levels are associated with cerebral amyloid load in presymptomatic autosomal dominant Alzheimer's disease.
    Brown BM; Sohrabi HR; Taddei K; Gardener SL; Rainey-Smith SR; Peiffer JJ; Xiong C; Fagan AM; Benzinger T; Buckles V; Erickson KI; Clarnette R; Shah T; Masters CL; Weiner M; Cairns N; Rossor M; Graff-Radford NR; Salloway S; Vöglein J; Laske C; Noble J; Schofield PR; Bateman RJ; Morris JC; Martins RN;
    Alzheimers Dement; 2017 Nov; 13(11):1197-1206. PubMed ID: 28501451
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cognition, brain atrophy, and cerebrospinal fluid biomarkers changes from preclinical to dementia stage of Alzheimer's disease and the influence of apolipoprotein e.
    Susanto TA; Pua EP; Zhou J;
    J Alzheimers Dis; 2015; 45(1):253-68. PubMed ID: 25524955
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Earliest amyloid and tau deposition modulate the influence of limbic networks during closed-loop hippocampal downregulation.
    Skouras S; Torner J; Andersson P; Koush Y; Falcon C; Minguillon C; Fauria K; Alpiste F; Blenow K; Zetterberg H; Gispert JD; Molinuevo JL;
    Brain; 2020 Mar; 143(3):976-992. PubMed ID: 32091109
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between biomarkers in cerebrospinal fluid and structural changes in the brain in patients with Alzheimer's disease.
    Li X; Li TQ; Andreasen N; Wiberg MK; Westman E; Wahlund LO
    J Intern Med; 2014 Apr; 275(4):418-27. PubMed ID: 24237038
    [TBL] [Abstract][Full Text] [Related]  

  • 12. PSEN1 mutation carriers present lower cerebrospinal fluid amyoid-β42 levels than sporadic early-onset Alzheimer's disease patients but no differences in neuronal injury biomarkers.
    Balasa M; Vidal-Piñeiro D; Lladó A; Antonell A; Bosch B; Castellanos F; Bargalló N; Bartres-Faz D; Molinuevo JL; Sánchez-Valle R
    J Alzheimers Dis; 2012; 30(3):605-16. PubMed ID: 22426017
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Cerebrospinal fluid biomarkers and proximity to diagnosis in preclinical familial Alzheimer's disease.
    Ringman JM; Coppola G; Elashoff D; Rodriguez-Agudelo Y; Medina LD; Gylys K; Cummings JL; Cole GM
    Dement Geriatr Cogn Disord; 2012; 33(1):1-5. PubMed ID: 22343824
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Default mode network connectivity is linked to cognitive functioning and CSF Aβ1-42 levels in Alzheimer's disease.
    Celebi O; Uzdogan A; Oguz KK; Has AC; Dolgun A; Cakmakli GY; Akbiyik F; Elibol B; Saka E
    Arch Gerontol Geriatr; 2016; 62():125-32. PubMed ID: 26515126
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Spatial patterns of atrophy, hypometabolism, and amyloid deposition in Alzheimer's disease correspond to dissociable functional brain networks.
    Grothe MJ; Teipel SJ;
    Hum Brain Mapp; 2016 Jan; 37(1):35-53. PubMed ID: 26441321
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study.
    Reiman EM; Quiroz YT; Fleisher AS; Chen K; Velez-Pardo C; Jimenez-Del-Rio M; Fagan AM; Shah AR; Alvarez S; Arbelaez A; Giraldo M; Acosta-Baena N; Sperling RA; Dickerson B; Stern CE; Tirado V; Munoz C; Reiman RA; Huentelman MJ; Alexander GE; Langbaum JB; Kosik KS; Tariot PN; Lopera F
    Lancet Neurol; 2012 Dec; 11(12):1048-56. PubMed ID: 23137948
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Amyloid-β and tau pathologies relate to distinctive brain dysconnectomics in preclinical autosomal-dominant Alzheimer's disease.
    Guzmán-Vélez E; Diez I; Schoemaker D; Pardilla-Delgado E; Vila-Castelar C; Fox-Fuller JT; Baena A; Sperling RA; Johnson KA; Lopera F; Sepulcre J; Quiroz YT
    Proc Natl Acad Sci U S A; 2022 Apr; 119(15):e2113641119. PubMed ID: 35380901
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Functional Disintegration of the Default Mode Network in Prodromal Alzheimer's Disease.
    Dillen KNH; Jacobs HIL; Kukolja J; Richter N; von Reutern B; Onur ÖA; Langen KJ; Fink GR
    J Alzheimers Dis; 2017; 59(1):169-187. PubMed ID: 28598839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Neurons derived from sporadic Alzheimer's disease iPSCs reveal elevated TAU hyperphosphorylation, increased amyloid levels, and GSK3B activation.
    Ochalek A; Mihalik B; Avci HX; Chandrasekaran A; Téglási A; Bock I; Giudice ML; Táncos Z; Molnár K; László L; Nielsen JE; Holst B; Freude K; Hyttel P; Kobolák J; Dinnyés A
    Alzheimers Res Ther; 2017 Dec; 9(1):90. PubMed ID: 29191219
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Lower functional connectivity of default mode network in cognitively normal young adults with mutation of APP, presenilins and APOE ε4.
    Su YY; Zhang XD; Schoepf UJ; Varga-Szemes A; Stubenrauch A; Liang X; Zheng LJ; Zheng G; Kong X; Xu Q; Wang SJ; Qi RF; Lu GM; Zhang LJ
    Brain Imaging Behav; 2017 Jun; 11(3):818-828. PubMed ID: 27189159
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 17.